Trial intelligence / Profile preview

Dose and duration of amoxicillin in young children with community-acquired pneumonia

ISRCTN76888927Phase 3Completed

Sponsor
University College London
Start
Feb 2017
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial of amoxicillin in community-acquired pneumonia (CAP) (4 arms), sponsored by University College London. Started Feb 2017; status: completed.

02

Drugs

amoxicillin
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on ISRCTN76888927.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN76888927.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call